Clinical Trial Update: Titrating-Dose of Lonafarnib in Combination With Ritonavir [Phase 2]

View source ↗

Summary

Phase 2 trial update on titrating-dose lonafarnib in combination with ritonavir for chronic delta hepatitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delta Hepatitis

Drugs mentioned

• Lonafarnib (lonafarnib)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Eiger BioPharmaceuticals | Conditions: Chronic Delta Hepatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-06-22